The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique : prevalence and effect of social shielding
OBJECTIVES: We sought to gain insight into the prevalence of COVID-19 and the impact stringent social distancing (shielding) has had on a large cohort of rheumatology (RD) follow-up patients from a single large UK centre.
METHODS: We linked COVID-19-related deaths, screening and infection rates to our RD population (1.2.20-1.5.20) and audited active rheumatology follow-up patients through survey data communicated via a linked mobile phone SMS message. We assessed epidemiology, effect of stringent social distancing (shielding) and quality of life (HRQoL) by Short Form 12 (SF12).
RESULTS: There were 10,387 active follow-up patients, 7911 had linked mobile numbers. 12/10,387 RD patients died from COVID-19 (0.12%); local population 4131/7,415,149 (0.12%). For patients with mobile phones, 1693/7911 (21%) responded and of these, 1605 completed the SF12. Inflammatory arthritis predominated 1174/1693 (69%); 792/1693 (47%) were shielding. Advice on shielding/distancing was followed by 1372/1693(81%). 61/1693 (4%) reported COVID-19 (24/61 shielding); medication distribution was similar in COVID and non-COVID patients. Mental SF12 (MCS) but not physical (PCS) component scores were lower in COVID (60) vs. non-COVID (1545), mean differences: MCS, - 3.3; 95% CI - 5.2 to - 1.4, P < 0.001; PCS, - 0.4; 95% CI, - 2.1 to 1.3). In 1545 COVID-negative patients, those shielding had lower MCS (- 2.1; 95% CI - 2.8 to - 1.4) and PCS (- 3.1, 95% CI - 3.7 to - 2.5), both P < 0.001.
CONCLUSIONS: Our full RD cohort had no excess of COVID deaths compared to the general local population. Our survey data suggest that shielding adversely affects both mental and physical health in RD. These data broaden our understanding of shielding, indicating need for further study.
Errataetall: |
CommentIn: Rheumatol Int. 2021 Jun;41(6):1187-1188. - PMID 33839886 |
---|---|
Medienart: |
E-Artikel |
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
---|---|
Enthalten in: |
Rheumatology international - 41(2021), 4 vom: 07. Apr., Seite 707-714 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Cleaton, N [VerfasserIn] |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 23.03.2021 Date Revised 16.07.2022 published: Print-Electronic CommentIn: Rheumatol Int. 2021 Jun;41(6):1187-1188. - PMID 33839886 Citation Status MEDLINE |
---|
doi: |
10.1007/s00296-021-04797-4 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM321201019 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM321201019 | ||
003 | DE-627 | ||
005 | 20231225175315.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1007/s00296-021-04797-4 |2 doi | |
028 | 5 | 2 | |a pubmed24n1070.xml |
035 | |a (DE-627)NLM321201019 | ||
035 | |a (NLM)33559727 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cleaton, N |e verfasserin |4 aut | |
245 | 1 | 4 | |a The impact of COVID-19 on rheumatology patients in a large UK centre using an innovative data collection technique |b prevalence and effect of social shielding |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 23.03.2021 | ||
500 | |a Date Revised 16.07.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a CommentIn: Rheumatol Int. 2021 Jun;41(6):1187-1188. - PMID 33839886 | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVES: We sought to gain insight into the prevalence of COVID-19 and the impact stringent social distancing (shielding) has had on a large cohort of rheumatology (RD) follow-up patients from a single large UK centre | ||
520 | |a METHODS: We linked COVID-19-related deaths, screening and infection rates to our RD population (1.2.20-1.5.20) and audited active rheumatology follow-up patients through survey data communicated via a linked mobile phone SMS message. We assessed epidemiology, effect of stringent social distancing (shielding) and quality of life (HRQoL) by Short Form 12 (SF12) | ||
520 | |a RESULTS: There were 10,387 active follow-up patients, 7911 had linked mobile numbers. 12/10,387 RD patients died from COVID-19 (0.12%); local population 4131/7,415,149 (0.12%). For patients with mobile phones, 1693/7911 (21%) responded and of these, 1605 completed the SF12. Inflammatory arthritis predominated 1174/1693 (69%); 792/1693 (47%) were shielding. Advice on shielding/distancing was followed by 1372/1693(81%). 61/1693 (4%) reported COVID-19 (24/61 shielding); medication distribution was similar in COVID and non-COVID patients. Mental SF12 (MCS) but not physical (PCS) component scores were lower in COVID (60) vs. non-COVID (1545), mean differences: MCS, - 3.3; 95% CI - 5.2 to - 1.4, P < 0.001; PCS, - 0.4; 95% CI, - 2.1 to 1.3). In 1545 COVID-negative patients, those shielding had lower MCS (- 2.1; 95% CI - 2.8 to - 1.4) and PCS (- 3.1, 95% CI - 3.7 to - 2.5), both P < 0.001 | ||
520 | |a CONCLUSIONS: Our full RD cohort had no excess of COVID deaths compared to the general local population. Our survey data suggest that shielding adversely affects both mental and physical health in RD. These data broaden our understanding of shielding, indicating need for further study | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Health care delivery | |
650 | 4 | |a Health service research | |
650 | 4 | |a Quality improvement | |
650 | 4 | |a Quality of life indicators | |
650 | 4 | |a Rheumatic disease | |
700 | 1 | |a Raizada, S |e verfasserin |4 aut | |
700 | 1 | |a Barkham, N |e verfasserin |4 aut | |
700 | 1 | |a Venkatachalam, S |e verfasserin |4 aut | |
700 | 1 | |a Sheeran, T P |e verfasserin |4 aut | |
700 | 1 | |a Adizie, T |e verfasserin |4 aut | |
700 | 1 | |a Sapkota, H |e verfasserin |4 aut | |
700 | 1 | |a Singh, B M |e verfasserin |4 aut | |
700 | 1 | |a Bateman, J |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Rheumatology international |d 1985 |g 41(2021), 4 vom: 07. Apr., Seite 707-714 |w (DE-627)NLM012644315 |x 1437-160X |7 nnns |
773 | 1 | 8 | |g volume:41 |g year:2021 |g number:4 |g day:07 |g month:04 |g pages:707-714 |
856 | 4 | 0 | |u http://dx.doi.org/10.1007/s00296-021-04797-4 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 41 |j 2021 |e 4 |b 07 |c 04 |h 707-714 |